Value of in situ ovarian volume measured during cesarean delivery to assess the potential of diminished ovarian reserve. (3rd May 2017)

• Record Type: Journal Article
• Authors: Karakus, Savas; Yildiz, Caglar; Aydin, Huseyin; Akkar, Ozlem; Cetin, Ali
• Is Part Of: Journal of maternal-fetal & neonatal medicine. Volume 30:Number 9(2017)
• Page Start: 1016
• Page End: 1022
• Publication Date: 2017-05-03
• Subjects: Anti-Müllerian hormone -- antral follicle count -- diminished ovarian reserve -- cesarean delivery -- ovarian volume; Obstetrics -- Periodicals; Perinatology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; Neonatology -- Periodicals; 618.2
• DOI: 10.1080/14767058.2016.1199670
• Languages: English
• ISSNs: 1476-7058

Abstract

Abstract: Objective : We aimed to determine the value of mean ovarian volume (OV) determined by three-dimensional in situ measurement of ovaries during cesarean delivery (CD) to assess the potential of diminished ovarian reserve (DOR) evaluated by hormonal and ultrasonographic parameters 3 months after the cesarean delivery. Methods : Each ovary was measured underwent CD in three dimensions, and three months after CD, the mean OV, serum AMH, FSH, LH, and estradiol levels, and antral follicle count (AFC) values were recorded as well as other demographic and obstetric parameters. Results : After categorizing the study subjects as having a potential of DOR by the criteria of serum AMH <1 pg/mL and AFC value ≤6, in patients with a potential of DOR, the mean intra-operative and post-operative OVs were significantly decreased ( p < 0.05). Considering the correlation coefficients obtained by the correlations of post-operative AMH level and AFC value with the mean intra-operative and post-operative OV values, the mean intra-operative OV provided significantly higher correlation coefficients ( p < 0.05). Conclusions : These findings, overall, support the diagnostic value of mean OV determined by the in situ measurement of three dimensions of left and right ovaries during cesarean delivery for the screening of potential for the DOR.